Avantor Inc AVTR
π Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2019-05-17 |
| Shares Out. | 676,360,000 |
| Website | avantorsciences.com/ β |
| Phone | 16103861700 |
| Employees | 13,500 |
| Revenue | $1.69B |
| Gross Profit | $537.0M |
| Net Income | $38.1M |
| Free Cash Flow | $454.7M |
| Total Assets | $11.60B |
| Total Liabilities | $5.97B |
| Equity | $5.63B |
About Avantor Inc
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Avantor Inc is a publicly traded company under the ticker symbol AVTR on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
25 analysts (2026-09-01)

